Sean Whooley

Gary Guthart, who spent the last 15 years as Intuitive’s CEO, called it “an honor and a privilege” to serve in the corner office.

Johnson & Johnson designed Dualto to deliver the choice of powering monopolar, bipolar, ultrasonic, or advanced bipolar instruments.

Versius is the second most-used soft-tissue surgical robot on the market and applies to a range of specialties, according to CMR Surgical.

Symphony Robotics said its goal is to reduce incision and craniotomy size to less than 4mm with its technology.

Intuitive plans to integrate its da Vinci and the Ion business operations into its European commercial and marketing organization.

Intuitive Surgical reported fourth-quarter 2024 revenue totaling $2.41 billion, a 25% increase compared with the same period a year ago.

The study found multiple benefits for surgery using Intuitive Surgical’s da Vinci robot compared with laparoscopic or open procedures.

Stereotaxis said the approval marks a significant milestone as it expands access to the minimally invasive robotic technology in China.

GE HealthCare said complex pulmonary and thoracic procedures require precise intraoperative imaging systems.

The regulatory nod for Ottava allows Johnson & Johnson MedTech to begin a clinical trial for the surgical robot at U.S. sites.

Stereotaxis said Genesis delivers the benefits of robotic precision and safety to cardiac ablation to treat arrhythmias.

Procept BioRobotics said its Aquablation procedure uses waterjet resection to precisely eradicate tissue without requiring full prostate removal.

Corin continues to expand its Unity Knee MC portfolio with its latest insert, compatible with its surgical robot.

Over the course of 2024, we’ve seen all kinds of stories across surgical robotics, ranging from new systems to FDA clearances and more.

The FDA cleared THINK Surgical’s miniature surgical robot for use with Zimmer Biomet’s Persona Knee System.

The judge deemed that J&J had declined to put resources toward advancing iPlatform and instead pitted it against its own Verb device.

Obvius Robotics aims to improve the accuracy, safety, and consistency of central venous catheterization with its Certa system.

KARL STORZ said its acquisition of Asensus Surgical will enable it to build a surgical robotics hub for performance-guided procedures.

Neptune Medical said the financing strengthens its position as a gastrointestinal-focused company expanding into robotics.

Dual-use system offers standalone navigation and an active robotics platform for flexibility in approach and planning.

Perceptive has developed and demonstrated a robot that uses imaging and AI for dental procedures such as crown placement.

Asensus Surgical denied any legal wrongdoing in statements around its planned merger and offered further information.